SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
45 hedge funds and large institutions have $109M invested in Sigilon Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
48% less capital invested
Capital invested by funds: $209M → $109M (-$99.8M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $246K
Holders
45
Holding in Top 10
1
Calls
–
Puts
$246K
Top Buyers
| 1 | +$1.9M | |
| 2 | +$1.3M | |
| 3 | +$897K | |
| 4 |
Millennium Management
New York
|
+$864K |
| 5 |
State Street
Boston,
Massachusetts
|
+$555K |
Top Sellers
| 1 | -$6.66M | |
| 2 | -$3.87M | |
| 3 | -$1.34M | |
| 4 |
ZDA
Zweig-DiMenna Associates
New York
|
-$1.27M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$909K |